|
|||||
|
|
| 组蛋白去乙酰化酶2在肝细胞癌组织中的表达及其临床意义 | |
| 引用本文： | 陈仲,林丽燕,程变巧,林仁河,蒋小玲. 组蛋白去乙酰化酶2在肝细胞癌组织中的表达及其临床意义[J]. 中国癌症防治杂志, 2021, 13(1): 62-66. DOI: 10.3969/j.issn.1674-5671.2021.01.11 |
| 作者姓名： | 陈仲 林丽燕 程变巧 林仁河 蒋小玲 |
| 作者单位： | 厦门大学附属福州第二医院神经内科；福建医科大学附属肿瘤医院，福建省肿瘤医院病理科；厦门大学附属福州第二医院肝胆内科 |
| 基金项目： | 福建省卫生健康科研人才培养项目:青年科研课题(2019-2-28);福建省卫生健康科研人才培养项目:青年科研课题(2018-1-15);福州市卫健委中青年科学研究项目(2019-S-wq16)。 |
| 摘 要： | 目的 探讨组蛋白去乙酰化酶2(histone deacetylase 2,HDAC2)在肝细胞癌组织中的表达及其与预后的关系.方法 采用Western blot法和免疫组化检测肝细胞癌组织及对应癌旁组织中HDAC2蛋白的表达情况,并分析其与患者临床病理学参数及预后的关系.结果 HDAC2蛋白在肝细胞癌组织中的表达明显高... |
| 关 键 词： | 肝细胞癌 组蛋白去乙酰化酶2 预后 |
Expression of histone deacetylase 2 in hepatocellular carcinoma and its clinical significance |
|
| CHEN Zhong,LIN Liyan,CHENG Bianqiao,LIN Renhe,JIANG Xiaoling. Expression of histone deacetylase 2 in hepatocellular carcinoma and its clinical significance[J]. Journal of Chinese Medical Abstracts·Oncology, 2021, 13(1): 62-66. DOI: 10.3969/j.issn.1674-5671.2021.01.11 | |
| Authors: | CHEN Zhong LIN Liyan CHENG Bianqiao LIN Renhe JIANG Xiaoling |
| Affiliation: | (Department of Neurology,Fuzhou Second Hospital Affiliated to Xiamen University,Fuzhou 350007,China;Department of Pathology,Fujian Medical University Cancer Hospital,Fujian Cancer Hospital,Fuzhou 350014,China;Department of hepatobiliary medicine,Fuzhou Second Hospital Affiliated to Xiamen University,Fuzhou 350007,China) |
| Abstract: | Objective To investigate the expression of histone deacetylase 2(HDAC2)in hepatocellular carcinoma(HCC)tissues and its relationship with prognosis.Methods The expression of HDAC2 protein in hepatocellular carcinoma and corresponding adjacent normal tissues were detected by the Western blot and immunohistochemical methods,and the relationship between the expression level of HDAC2 and clinicopathological parameters and prognosis was analyzed.Results The expression of HDAC2 protein in HCC tissues was significantly higher than that in normal tissues(P=0.025),and its expression level was correlated with tumor differentiation,vascular invasion and relapse(all P<0.05).Multivariable Cox analysis showed that the high expression of HDAC2 was an independent risk factor for overall survival of patients with hepatocellular carcinoma(HR=12.255,95%CI:2.865-52.411,P=0.001).Conclusion HDAC2 is highly expressed in HCC tissues,and patients with high expression of HDAC2 have poor prognosis,implying that it can be a molecular marker for prognosis of HCC. |
| Keywords: | Hepatocellular carcinoma Histone deacetylase 2 Prognosis |
| 本文献已被 维普 等数据库收录！ | |
| 点击此处可从《中国癌症防治杂志》浏览原始摘要信息 | |
| 点击此处可从《中国癌症防治杂志》下载免费的PDF全文 | |